Optimising the diagnostic value of Anti- Saccharomyces cerevisiae -antibodies (ASCA) in Crohn?s disease
- 27 January 2004
- journal article
- research article
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 19 (4), 319-324
- https://doi.org/10.1007/s00384-003-0557-1
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Association of Perinuclear Antineutrophil Cytoplasmic Antibodies and Anti–Saccharomyces cerevisiae Antibodies With Vienna Classification Subtypes of Crohn's DiseaseInflammatory Bowel Diseases, 2003
- Assessment and relevance of enzyme-linked immunosorbent assay for antibodies toSaccharomyces cerevisiaein Australian patients with inflammatory bowel diseaseInternal Medicine Journal, 2002
- The value of serologic markers in indeterminate colitis: A prospective follow-up studyGastroenterology, 2002
- Evaluation of Serologic Disease Markers in a Population-Based Cohort of Patients with Ulcerative Colitis and Crohn's DiseaseInflammatory Bowel Diseases, 2001
- Comparative study of ASCA (Anti–Saccharomyces cerevisiae antibody) assays in inflammatory bowel diseaseGastroenterology, 2001
- Anti-Saccharomyces cerevisiae Antibodies in Inflammatory Bowel Disease: a Family StudyScandinavian Journal of Gastroenterology, 2001
- Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristicsGut, 2000
- Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic roleGut, 1998
- Antineutrophil and Pancreatic Autoantibodies in First-Degree Relatives of Patients with Inflammatory Bowel DiseaseScandinavian Journal of Gastroenterology, 1998
- Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens?European Journal of Gastroenterology & Hepatology, 1996